The Patent Trial and Appeal Board (PTAB) has issued a series of discretionary denial decisions, affecting patent holder companies in different ways. Notably, Nike Inc. and Cleveland Medical Devices have been exempted from further patent scrutiny, whereas Vermeer Manufacturing Co. did not receive such an exemption. These decisions exemplify PTAB’s approach in handling requests on a case-by-case basis, potentially impacting strategies for companies involved in patent litigation.
For more detailed information, visit the full article on Law360.